Register entry
Laboratorium Ofichem BV
- Registered sites
- 1
- Drug products
- 21
- Live patents
- 0
- Countries
- 1
- Base
- Netherlands
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Laboratorium Ofichem BV | Ter ApelNetherlands | Active ingredient (API) manufacture | 1000286391 |
Catalogue
Marketed products
21Showing 21 of 21.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Calcium Monoethylfumarate | POWDER | BULK INGREDIENT |
| - | Calcium Monoethylfumarate Micronized | POWDER | BULK INGREDIENT |
| - | Dimethyl Fumarate | POWDER | BULK INGREDIENT |
| - | Dimethylfumarate Micronized | POWDER | BULK INGREDIENT |
| - | Edetate Calcium Disodium | POWDER | BULK INGREDIENT |
| - | Guanabenz Acetate | POWDER | BULK INGREDIENT |
| - | Histamine Dihydrochloride | POWDER | BULK INGREDIENT |
| - | Magnesium Monoethylfumarate | POWDER | BULK INGREDIENT |
| - | Magnesium Monoethylfumarate Micronized | POWDER | BULK INGREDIENT |
| - | Methenamine Mandelate | POWDER | BULK INGREDIENT |
| - | Palmitoylethanolamide | POWDER | BULK INGREDIENT |
| - | Pamidronate Disodium Pentahydrate | POWDER | BULK INGREDIENT |
| - | Potassium Bromide | POWDER | BULK INGREDIENT |
| - | R-Buproprion Hydrochloride | POWDER | BULK INGREDIENT |
| - | Reboxetine Mesylate | POWDER | BULK INGREDIENT |
| - | S,S-Reboxetine Succinate | POWDER | BULK INGREDIENT |
| - | S-Buproprion Hydrochloride | POWDER | BULK INGREDIENT |
| - | Sulfadiazine Sodium | POWDER | BULK INGREDIENT |
| - | Zinc Acetate Dihydrate Milled | POWDER | BULK INGREDIENT |
| - | Zinc Monoethylfumarate | POWDER | BULK INGREDIENT |
| - | Zinc Monoethylfumarate Micronized | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.